Using betahistine in the treatment of patients with Meni ère's disease: a meta-analysis with the current randomized-controlled evidence.

Conclusions and Significance: There is a need for further well-conducted placebo RCTs. Currently, there is still a lack of substantial evidence supporting betahistine as a significant and adequate treatment for patients diagnosed with Menière's disease. Trial registration number: The protocol is registered in PROSPERO. Registration number: CRD42018110127 Accepted 11.10.2018.
PMID: 32580600 [PubMed - as supplied by publisher]

Source: Acta Oto-Laryngologica - June 24, 2020 Category: ENT & OMF Authors: Devantier L, Hougaard D, Händel MN, Liviu-Adelin Guldfred F, Schmidt JH, Djurhuus B, Callesen HE Tags: Acta Otolaryngol Source Type: research